Thursday, 21 December 2017

Limited Time Offer – $30 off Dividend.com Premium


Trouble viewing this?
View Email as Webpage

Get $30 Off Dividend.com Premium

Limited Time Offer


Click to Use Coupon Code: XMAS2017

Christmas Sale!

In the spirit of doing what we're passionate about—helping millions of investors with their dividend portfolios—we're taking this holiday opportunity to offer our Dividend.com Premium service at a very special low price.

Not only will you be able to get Dividend.com Premium at such a low rate, but you will also unlock ALL NEW additions to our Best Dividend Stocks list.


Act Now So You Don't Miss Out...

This offer won't last long. Save $30.00 off our regular price during your first year when you upgrade your Dividend.com Premium account for $119.00.
 
 
THIS WEEK'S FEATURED STOCK

Global Healthcare Company Remains Atop Best Dividend Stocks List

If there’s one pervasive problem with many of the healthcare giants, it’s the so-called patent cliff. With many blockbuster drugs and therapies falling off patent protection, their hefty cash flows and earnings are at risk of also falling by the wayside. But that’s not the case for our Best Dividend Stock List’s global healthcare pick.

It’s been smartly using its cash flows and healthy balance on a solid dose of biotech innovation as well as smart bolt-on M&A deals.

This has refreshed its patent portfolio and allowed our pick to steer clear of the impending patent cliff. Perhaps, more importantly, its given investors more avenues for long-term growth down the road.

Perhaps the best part is that these efforts to find new growth will continue to keep our pick’s dividend moving along. Already considered a Dividend Aristocrat, our pick has paid dividends for over 50 years. With higher cash flows produced from these new drugs, it should be able to pay investors for another 50.

 

Here are 5 reasons why you should own this stock:

  1. Dividend Aristocrat that has raised its dividend for 55 years in a row.
  2. Massive patent portfolio of drugs that has only gotten bigger through smart biotech M&A.
  3. Generated more than $15.5 billion in free cash flows last year alone.
  4. Operations in more than 80 countries and global leader in seven consumer healthcare categories.
  5. Low payout ratio of 46% and growing yield of ~2.40%.
Stock Symbol 95bac5d8-3e33-4ef5-b315-24f8d48112ff.png Unlock   Company Name 95bac5d8-3e33-4ef5-b315-24f8d48112ff.png Unlock
DARS Rating 3.9   Ex-Div Date 95bac5d8-3e33-4ef5-b315-24f8d48112ff.png Unlock
Current Yield ~2.40%   Pay Date 95bac5d8-3e33-4ef5-b315-24f8d48112ff.png Unlock
All data in table above updated as of 12/07/2017.

As a dividend investor, you need access to the best and safest stocks on the market. Dividend.com’s DARS ratings have been providing you with reliable and profitable stock analysis since 2008, and this addition is no exception.

Upgrade to Dividend.com Premium,
Get $30 off and Unlock This Stock
Our mailing address is:
Dividend.com P.O. Box 822 New York, NY 10108 USA

Update Subscription Options | Unsubscribe From This List | Forward to a Friend

©2017 Dividend.com. All rights reserved. You are receiving this mailing because you opted-in at our website, Dividend.com, which is in full compliance of the CAN-SPAM Act of 2008.

Mitre Media

No comments:

Post a Comment